Review for 10.1186/s12876-021-01846-x (2021)

Reviewer’s report
Title: 
Mucormycosis Causing Massive Lower Gastrointestinal Bleeding: A Case
Report
Version: 
1 
Date: 
14 May 2021
Reviewer's report:
REVISION ASSESSMENT FROM THE ACADEMIC PEER REVIEWER: 
Has the author addressed your concerns sufficiently for you to now recommend
the work as a technically sound contribution? Yes
Reviewer comments: OVERALL IMPRESSION
This is an unusual case but one that offers educational value for
immunocompromised individuals with lower GI bleeding. GI mucormycosis
should be at least considered in the differential diagnosis of such patients even in
the absence of fever.
HAVE THE AUTHORS RESPONDED ADEQUATELY TO EACH OF THE
QUESTIONS YOU RAISED IN YOUR COMMENTS
The authors have addressed appropriately all 
my suggestions 
HAVE THEY MADE THE APPROPRIATE CHANGES IN THE
MANUSCRIPT 
Yes thank you authors this now clarifies the points I raised—- well done !
REQUESTED REVISIONS: 
ARE THERE ADDITIONAL REVISIONS THE AUTHORS SHOULD MAKE-
CONSIDER 
I have re-read all the manuscript 
1. Line 69 change "to " to "for"
2. 
Line 77 change "of" to " for"
3. 
Line 104. Here you abbreviate hemoglobin as Hb but not on line 96. I would
write it out
4. Line 105 change to "were"
5. Line 126. Change "are" to " is"
6 lone 128 after the word "as" add the phrase"immunosuppression because of "
7. Line 133 agh the phrase "one of" after the word "is" the grammar is better
8. Line 135. This phrasing is very awkward. Reword after the word "or" to
"infection of an implanted device" 
if indeed that is what you mean by device
9. Line 139 delete the phrase " it has been reported" because your add a
reference. And replace that phrase by "Interestingly,"
10. Line 140 change make to "makes the"
11. Line 147. What do you mean by "dark"? Maybe your should say "A dark
appearing ulcer with sharp demarcated edges apparently related to necrosis and
thrombosis***"
12. Line 157 add the phrase "pharmacological immunosuppression 
because of
organ transplantation or diseases requiring immunosuppressive medications"
after the word "DKA
13. Line 158 delete the word 
the word "prophylaxis" and change to "empiric"
14. Line 160 add the phrase "in patients who" after the word LGIB"
15. Line 167 start the sentence with "the"
16. Line 173 change "succession of alcohol drinking" to "treatment of
alcoholism" 
17. Line 183 delete prophylaxis" and change to " empiric treatment of possible
fungal infection" 
OTHER CHANGES THAT THE AUTHORS SHOULD CONSIDER 
There are minor grammatical edits that are necessary. Your journal editors can
do this in addition to many of my suggestions 
Publons Reviewer Recognition
. Springer Nature can send verification of this
review directly to Publons (a subsidiary of Clarivate Analytics). If you would
like to take advantage of this service, please click on the “Yes” option below.
Your name, email address, title of the reviewed manuscript, name of the journal,
and date of your review submission (the “Review Data”) will then be transmitted
to Publons after the final decision on the manuscript has been made. If you have
already registered at Publons, they will notify you of the receipt of this review
and update your profile 
as per your settings and their policy. If you are not
registered with Publons, you will receive an email from them asking you to
register in order for them to be able to recognize your review on your new
profile page. Publons may use the Review Data to generate derivative metadata
for the benefit of Publons and you as a reviewer, carefully considering the
sensitivity of such information. For example, Publons may verify your record as
a reviewer by updating your profile published on its webservice if you have
registered for such service or help editors to identify candidate reviewers. Please
find the details of processing in Publons’ privacy policy
https://publons.com/about/terms
No
Declaration of competing interests
Please complete a declaration of competing
interests, considering the following questions:
1
. 
Have you in the past five years received reimbursements, fees, funding, or
salary from an organisation that may in any way gain or lose financially
from the publication of this manuscript, either now or in the future?
2
. 
Do you hold any stocks or shares in an organisation that may in any way
gain or lose financially from the publication of this manuscript, either now
or in the future?
3
. 
Do you hold or are you currently applying for any patents relating to the
content of the manuscript?
4
. 
Have you received reimbursements, fees, funding, or salary from an
organization that holds or has applied for patents relating to the content of
the manuscript?
5
. 
Do you have any other financial competing interests?
6
. 
Do you have any non-financial competing interests in relation to this
paper?
If you can answer no to all of the above, write 'I declare that I have no competing
interests' below. If your reply is yes to any, please give details below.
This reviewer has been recruited by a partner organization, Research Square.
Reviewers with declared or apparent competing interests are not utilized for
these reviews. This reviewer has agreed to publication of their comments online
under a Creative Commons Attribution License attributed to Research Square
and was paid a small honorarium for completing the review within a specified
timeframe. Honoraria for reviews such as this are paid regardless of the reviewer
recommendation.
Reviewer Publication Consent.
 I agree for my report to be made available
under an Open Access Creative Commons CC-BY License (
http://creativecommons.org/licenses/by/4.0
) if this manuscript is accepted for
publication. Any comments that I do not wish to be included in the published
report have been included as confidential comments to the editor, which will not
be published.
If you are not happy for us to publish this report, please contact the
editorial office before completing the review.
If you wish, you can include your
name in your published report. Please note you must decide whether to include
your name at the start of the process and confirm this decision whenever
prompted. If you change your decision later, we will not be able to publish your
name.
I agree to the terms of the CC-BY 4.0 license; please 
do not
 publish my name
with my report. (default)
Is the study design appropriate to answer the research question (including the use
of appropriate controls), and are the conclusions supported by the evidence
presented?
No
Are the methods sufficiently described to allow the study to be repeated?
No
Is the use of statistics and treatment of uncertainties appropriate?
No
Is the presentation of the work clear?
Yes
Are the images in this manuscript (including electrophoretic gels and blots) free
from apparent manipulation?
Yes